Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome
Author(s)
Type
Journal Article
Date Issued
2004-06-14
ISSN
0007-0920
Publisher
NATURE PUBLISHING GROUP
Start Page
2326
End Page
2331
Journal / Book Title
BRITISH JOURNAL OF CANCER
Volume
90
Issue
12
Copyright Statement
© 2004 Cancer Research UK. Publisher's version/PDF may be used after 12 months embargo, under a Creative Commons Attribution Non-Commercial Share Alike License
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000222427100011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
cervical cancer
neoadjuvant chemotherapy
magnetic resonance imaging
magnetic resonance spectroscopy
outcome
H-1 MR SPECTROSCOPY
BULKY STAGE IB
BRAIN-TUMORS
IN-VIVO
RANDOMIZED-TRIAL
CARCINOMA
CELL
SURVIVAL
SURGERY
RADIOTHERAPY
Adult
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cisplatin
Female
Humans
Hysterectomy
Leucovorin
Magnetic Resonance Imaging
Methotrexate
Middle Aged
Neoadjuvant Therapy
Radiotherapy, Adjuvant
Survival Analysis
Treatment Outcome
Uterine Cervical Neoplasms
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status
Published
